To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Low Molecular-weight Hyaluronic Acid vs. Physiotherapy for Supraspinatus Tendinopathy

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2022

Low Molecular-weight Hyaluronic Acid vs. Physiotherapy for Supraspinatus Tendinopathy

Vol: 177| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Low Molecular-weight Hyaluronic Acid Versus Physiotherapy for the Treatment of Supraspinatus Tendinopathy: A Randomized Comparative Clinical Trial

J Am Acad Orthop Surg. 2021 Oct 1;29(19): e979-e992.

Contributing Authors:
Z Rezasoltani H Esmaily A Dadarkhah M Rousta R Mohebbi F Vashaei

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Fifty-six patients with supraspinatus tendinopathy were randomized to receive a single injection of low molecular-weight hyaluronic acid (n=28) or 12 weeks of physical therapy (n=28). Outcome of interest included pain at rest and during activity, range of motion, disability scores, and quality of life. Results revealed significantly greater improvement in shoulder pain at rest and during activitie...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.